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Croton campestris A. St.-Hill., popularly known as “velame do campo,” is a species native to the savannah area of Northeast Brazil,
which is used by traditional communities in folk medicine for variety of health problems, especially detoxification, inflammation,
and gastritis. The hydroalcoholic extract of C.campestrisleaves(HELCC)wasassessedforitsantiulcerogeniceffectingastriclesion
models and effect on intestinal motility in mice, and possible mechanisms of action were examined. HELCC showed significant
gastroprotectiveactioninallmodelsofgastriculcerevaluated;the resultssuggest that thisaction probably involves the nitricoxide
pathway. HELCC did not show alteration of intestinal motility in mice. It was also found that C. campestris represents a promising
natural source with important biological potential, justifying some of its uses in folk medicine.
1. Introduction
Peptic ulcer is a term used to describe a group of ulcerative
disorders that occur in areas of the upper gastrointestinal
tract, which are exposed to acidic secretions and pepsin. It
represents a chronic health problem. Approximately 10% of
thepopulationhaveorwilldeveloppepticulcer.Itsincidence
is slightly higher in men than women (1.3:1), and although
it occurs at any age, duodenal ulcer occurs most often in the
rangeof30–55years,whereasgastriculceroccursintherange
of 50–70 years [1].
In Brazil, despite the absence of epidemiological records
of ulcer cases, it is known that there are numerous cases in-
volving this disease, which means a significant public health
problem prompting the search for new substances with anti-
ulcerogenicactivity.Althoughthereisalargearsenalofdrugs
with antiulcerogenic activity on the market, none produces
100% remission of ulcers, with reduced side effects and
without compromising the patient’s wellbeing, which usually
results in chronic use of these drugs. Published studies have
reported the widespread identification of new drugs derived
from natural antiulcerogenic sources [2].
Studies have shown that lipid peroxidation and oxidative
reactions are implicated in the pathogenesis of lesions
induced by ethanol by attacking biological molecules and
prostaglandins.Thus,researchinanimalmodelshasattracted
the interest of many investigators as a promising source for
the discovery of new drugs [3–5].
ThegenusCroton,whosenamemeans“tick,”isthesecond
largest in the family Euphorbiaceae and belongs to the sub-
family Crotonoidae Crotoneae and tribe [6]. It is subdivided
into 40 sections and has more than 1,300 species of mainly
pantropical distribution, of which 350 species in 29 sections2 Evidence-Based Complementary and Alternative Medicine
occurinBrazil[7].Ofthese,atotalof52speciesin18sections
are referred to Northeast Brazil [8].
Several species of Croton have long played an important
role in traditional uses of medicinal plants in Africa, Asia,
and South America, including the treatment of cancer, con-
stipation, diarrhea, and other digestive problems, diabetes,
external wounds, fever, hypercholesterolemia, hypertension,
inflammation, intestinal worms, malaria, pain, ulcers, and
obesity [9].
StudiesinvolvingseveralspeciesofthegenusCroton have
shown different pharmacological activities such as anti-
inflammatory and antioxidant activities of C. celtidifolius
[10], antileishmanial effect of C. cajucara [11], antinociceptive
effectofC.cajucara[12],antiulcerogenicandcytotoxicactivi-
tiesofC.cajucara[13],hypoglycemicandhypolipidemicpro-
perties of C. cajucara [14], antimicrobial and the antimalarial
effects C. kongensis [15], antinociceptive and anti-inflam-
matory properties of C. malambo [16], antimicrobial effect of
C. sonderianus [17], purgative effect of C. campestris [18], and
hypotensive and narcotic activities of C. eluteria [19].
As t u d yo fC. campestris in the traditional community of
thebioregionofChapadadoArariperevealedthepopularuse
oftheleavesandrootsofthisplantforgastric,hematological,
and inflammatory disturbances, wounds, and respiratory
problems. For their medicinal uses, the local population
utilizes infusion in alcoholic beverages, teas, and macerates,
which justifies the use of the hydroalcoholic extract for the
verification of the antiulcer activity.
The hydroalcoholic extract of leaves of C. campestris A.
St.-Hill (HELCC) was assessed for its antiulcerogenic effect
in models of gastric lesions using absolute ethanol, acidified
ethanol, and indomethacin, and mechanisms of action were
examined. The effect of HELCC on gastric motility was also
ruled out.
2. Materials and Methods
2.1. Plant Material. The leaves of the plant species Croton
campestris A. St.-Hill were collected in the municipality of
Crato,Cear´ a,Brazil,usingaGPSdevice(7
∘ 22
򸀠 2.8
򸀠򸀠 S;39
∘ 28
򸀠
42.4
򸀠򸀠 W; altitude: 892 meters). The procedures for specimen
preparation followed the recommendations described by
Ming 1996 apud Di Stasi, 1996. The material was deposited
in the Herbarium of the Federal University of Rio Grande do
Norte (UFRN) and registered under no. 7095. The research
was reviewed by the Ethics Committee for Animal Research,
CEPA, Faculty of Medicine of Juazeiro do Norte (FMJ), and
was approved (case no. 2009 0432 FR 271610).
2.2.PreparationofHydroalcoholicExtractoftheLeavesofCro-
tonCampestrisA.St.-Hill(HELCC). Theplantmaterial(fresh
leaves: 852g C. campestris) was washed under running water,
crushed and macerated, and then submitted to cold extrac-
tionwith99.9%ethanolandwaterina1:1proportion(8.7Lof
solvent). The solvent was removed using a rotary evaporator
under reduced pressure and temperature of 40–50
∘C, and a
yieldof70.89gcrudeextractwasobtainedusingalyophilizer.
2.3. Phytochemical Screening. The material was submitted to
phytochemical screening for the presence of tannins,
flavonoids, saponins, steroids, triterpenes, coumarins, quin-
ones, organic acids, and alkaloids. Accordingly, the hydro-
alcoholic extract (0.3g) was diluted in distilled water (9mL)
and 70% ethanol (21mL) and after dilution, distributed into
six flasks, in which the tests for different compounds were
performed. Phenols and tannins: 3 drops of ferric chloride
were added to the flask, and development of a blue color
d e n o t e dt h ep r e s e n c eo fp y r o g a l l i ct a n n i n s ,w h i c hc o u l db e
further confirmed with the addition of gelatin, resulting in a
precipitate with the sample. Anthocyanins, anthocyanidins,
and flavonoids: the sample was acidified (pH 3) by the addi-
tion of 18 drops of HCl, and no change in color of the flask
demonstrated the presence of flavones, flavonols, xanthones,
and flavanonols.
The test for leucoanthocyanidins, catechins, and flavon-
ones was performed by alkalinization to pH 8.5 with 1%
sodium hydroxide in the first flask, acidification (pH 3) by
means of 18 drops of HCl and heatingfor2min in the second
flask, and alkalinization (pH 11) with 18 drops of 1% NaOH
a n da l s oh e a t i n gf o r2m i ni nt h et h i r dfl a s k .Th u s ,fl a s k2
d i dn o ts h o wac h a n g ei nc o l o r ,d e m o n s t r a t i n gt h ep r e s e n c e
of flavonones, and still the orange red color of flask 3 also
revealed the presence of flavonones. The test for chalcones
and aurones, by alkalinization (pH 11) with 18 drops of 1%
N a O H ,g a v eap u r p l er e dc o l o ri nt h efl a s k ,i n d i c a t i n gt h e
presence of these compounds.
The test for alkaloids was done by diluting the extract
(0.3g) in 30mL of 5% acetic acid and 15mL of ammonia for
alkalinization. The preparation was heated until boiling, and
10mL of 10% ammonium hydroxide was then added, along
with 15mL of chloroform. After homogenization and allow-
ing to stand in a separatory funnel, the chloroform phase was
c o l l e c t e di nab e a k e r ,a n dt h es o l v e n tw a se v a p o r a t e d .Th e
r e s i d u ew a sr e s u s p e n d e di n1 %H C la n dh o m o g e n i z e d ,a n d
solution was placed on a slide along with a drop of Dragen-
dorff reagent, where the formation of a precipitate was indi-
c a t i v eo ft h ep r e s e n c eo fa l k a l o i d s .
The test for steroids and triterpenoids was carried out by
dilutionoftheextract(0.3g)in6mLofchloroformandfiltra-
tion using cotton covered with sodium sulfate, collecting the
filtrateinatesttube.Aftertheadditionof0.1mLofanhydrous
acetic acid and three drops of sulfuric acid, the development
of a green color indicated the presence of steroids [20].
2.4. Assays
2.4.1.AssessmentofOralAcuteToxicity. Swissmicewereused
throughout to evaluate HELCC for toxicity and effect on
gastric lesions. The animals were fasted for 3h prior to the
experiment and were given a single dose of extract dissolved
in2%w/vTween80at17.5,55,175,550,2000,and5000mg/kg
and observed for mortality for up to 48h (short-term toxi-
city). Based on the short-term toxicity, the dose of the next
animal was determined as per OECD guideline 425. All
animals were also observed for long-term toxicity (14 days).
The LD50 of the test extracts was calculated using “AOT 425”Evidence-Based Complementary and Alternative Medicine 3
software provided by the Environmental Protection Agency,
USA [21].
2.5. Gastric Lesions Induced by Ethanol [22]. The mice were
divided into groups (𝑛 = 6),f a s t e df o rap e r i o do f1 5ha n d
treated with HELCC (50, 75, 125, 250, 500, and 750mg/kg,
p.o.), omeprazole (30mg/kg, p.o.), or vehicle (saline, 0.1mL/
10g, p.o.) 1h before administration of absolute ethanol
(0.2mL/animal, p.o.). After 30min, the animals were sacri-
ficed by cervical dislocation. Their stomach was removed,
opened along the greater curvature, and rinsed with saline
and digitized; the ulcerated area was expressed as a percent-
age relative to the total area of the gastric body using ImageJ
software.
2.6. Gastric Lesions Induced by Acidified Ethanol [23]. The
mice were treated with HELCC (50, 75, 125, 250, 500, and
750mg/kg, p.o.), omeprazole (30mg/kg, p.o.), or vehicle
(saline, 0.1mL/10g, p.o. for the control lesion group). One
hour after treatment, the animals received 0.2mL of 0.3M
hydrochloric acid (HCl) in 60% ethanol and were sacrificed
1h later. The percentage of stomach ulceration was deter-
mined as described above.
2.7. Gastric Lesions Induced by Indomethacin [24]. The mice
were pretreated with HELCC (250, 500, and 750mg/kg, p.o.),
omeprazole (30mg/kg, p.o.), or vehicle (saline, 0.1mL/10g,
p.o. for the control lesion group). Six hours after administra-
tion of the ulcerogenic agent (indomethacin, 10mg/kg, s.c.),
the animals were sacrificed. The percentage of stomach
ulceration was determined as described above.
2.8. Evaluation of the Mechanism of Action of Gastroprotective
HELCC. To determine the mechanism of action, experi-
mentswereperformedtoseparatelyexaminetheinvolvement
of 𝗼-2 receptors, prostaglandins [23], nitric oxide [25], and
ATP-dependent K
+ channel activation [26]i nt h eg a s t r o p r o -
tective effect of HELCC (75mg/kg, p.o.). These experi-
ments used the appropriate antagonists including yohim-
bine (2mg/kg, i.p.), indomethacin (10mg/kg, p.o.), L-NAME
(10mg/kg, i.p.), and glibenclamidee (5mg/kg, p.o.) or ago-
nistsincludingL-arginine(600mg/kg,p.o.)asapositivecon-
trol for L-NAME and misoprostol (0.016mg/kg, p.o.) as a
control for indomethacin before the oral administration of
0.2mL of 96% ethanol.
Ineachcase,theanimalswerepretreatedwiththespecific
antagonist or agonist for 30min before the administration
of HELCC. Finally, 0.2mL of 96% ethanol was orally admin-
i s t e r e do n eh o u ra ft e rH E L C C .Th ea n i m a l sw e r et h e ns a c r i -
ficed, and their stomach was removed, opened along the
gr ea t ercurva t ur e ,wa s h edinsalin e ,a n dco m p r es sedbetw een
glass slides for better viewing. The slides were scanned at
1200dpi. The percentage area of gastric lesions (glandular
portion)wasdeterminedwiththeaidofImageJsoftware.The
injured area is expressed as a relative percentage of the total
area of the gastric body [23, 26].
2.9. Effect of HELCC on Intestinal Motility [27]. The ani-
mals were treated with HELCC (75mg/kg, p.o.), vehicle
(saline,0.1mL/10g,p.o.),oratropine(0.01g/kg,p.o.)and10%
activated charcoal (0.1mL/10g, p.o.). HELCC, atropine, or
vehicle was administered first, followed by activated char-
coal 1h later. Thirty minutes after charcoal administration,
the animals were sacrificed, and their small intestine was
removed. The total length of the intestine (the pyloric region
to the ileocecal junction) was then measured; the distance
traveled by the charcoal was determined based on the dis-
tance from the pylorus to the last portionof the intestine that
containedatleast1cmofcontinuouscharcoal.Thirtyminutes
after administration of the charcoal, the animals were sacri-
ficed and analyzed as described above.
2.10. Statistical Analysis. Data are presented as the mean ±
standard deviation. The level of significance was 0.05. Dif-
ferences between the means were determined by analysis of
variance (ANOVA), and the Newman-Keuls test was used to
determine statistical significance. Analyses were performed
using GraphPad Prism software version 5.0.
3. Results
Phytochemicalprospecting[20]ofHELCCidentifiedthepre-
sence of tannins flavonols, flavones, flobabenics, flavanone,
flavonals, xanthones, terpenes, and alkaloids (Table 1), possi-
b l yi n v o l v e di nt h eb i o a c t i v ep r o p e r t i e se v a l u a t e d .
3.1. Toxicological Data. HELCC did not show evidence of
a c u t et o x i c i t y .Th ed a i l ym o n i t o r i n go fw e i g h to fa n i m a l sd i d
not indicate a significant variation compared to the control
group(saline).Therewerenosignsofmorbidityordeathjust
after extract administration, or during the period of obser-
vation and weighing (14 days after treatment) in the group
treated orally. The median lethal dose (LD50) for the oral
administration of HELCC was greater than or equal to
5000mg/kg, with a 95% confidence interval.
Theanimalsshoweddecreasedactivityandmilddyspnea,
showing recovery within four hours.
3.2. Gastroprotection Tests. The effects of HELCC on gastric
lesions induced by absolute ethanol (0.2mL/animal, p.o.) are
shown in Figure 1.Th ea n i m a l st h a tr e c e i v e do n l yv e h i c l e
combined with oral administration of absolute ethanol
showed an extensive area of gastric lesion (18.57 ± 1.87%).
HELCCproducedamarkedreductionintheareadamagedby
absolute ethanol at all doses tested: 1.34 ± 0.66% at 50mg/kg
(92.78%reduction),1.11±0.67%at75mg/kg(94.02%),0.93±
0.43%a t1 2 5 m g / k g( 9 4 . 9 9 % ) ,0.87 ± 0.54%a t2 5 0 m g / k g
(95.31%), 0.82 ± 0.31% at 500mg/kg (95.58%), and 0.53 ±
0.16% at 750mg/kg (97.14%), when compared to the control
(𝑃 < 0.001inallcases).Theanimalsthatreceivedomeprazole
(30mg/kg, p.o.) also showed a significant decrease in gastric
lesion area and a substantial reduction percentage in ulcer
area, that is, 0.78±0.34% and95.79%, respectively, compared
to control (𝑃 < 0.001).
TheeffectsofHELCCongastriclesionsinducedbyacidi-
fied ethanol (0.2mL/animal, p.o.) are shown in Figure 2.4 Evidence-Based Complementary and Alternative Medicine
Table 1: Prospecting photochemistry of hydroalcoholic extract of
lyophilized of leaves of Croton campestris A. St.-Hill.
Metabolites (+) presence
(−) absence
Phenols −
Pyrogallic tannins −
Flobabenic tannins +
Anthocyanins −
Anthocyanidins −
Flavones +
Flavonols +
Xanthones +
Chalcones −
Aurones −
Flavanonols +
Leucoanthocyanidin −
Catechin −
Flavonone +
Alkaloids +
Terpenes +
Steroids −
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Figure 1: Effect of oral administration of the HEFCC in gastric
lesions induced by ethanol abs in mice. Significance
∗∗∗𝑃 < 0.001
when compared with control group.
The animals that received only vehicle combined with oral
administration of acidified ethanol showed an extensive area
of gastric lesion (23.19±3.09%).H E L C Cs h o w e ds u b s t a n t i a l
reduction in the areas damaged by acidified ethanol, at all
doses tested: 3.04±0.80% at 50mg/kg (reductionof 86.89%),
1.94±0.70% at 75mg/kg (91.63%), 1.67±0.75%a t1 2 5m g / k g
(92.79%), 2.40 ± 0.99%a t2 5 0m g / k g( 8 9 . 6 5 % ) ,0.52 ± 0.30%
at 500mg/kg (97.75%), and 0.59 ± 0.26%a t7 5 0 m g / k g
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Figure 2: Effect of oral administration of the HEFCC in gastric
lesions induced by acid ethanol in mice. Significance
∗∗∗𝑃 < 0.001
when compared with control group.
(97.45%), respectively, when compared to the control (𝑃<
0.001 in all cases). The animals that received omeprazole
(30mg/kg, p.o.) also showed a significant reduction in the
injured areas and a high percentage reduction in ulcer area,
that is, 3.58 ± 0.56% and 84.56%, respectively, compared to
control (𝑃 < 0.001).
Theeffects of HELCCon gastriclesionsinduced by indo-
methacin (10mg/kg, s.c.) are shown in Figure 3.Th ea n i m a l s
that received only vehicle combined with s.c. administration
ofindomethacinshowedalargeareaofgastriclesion(12.61±
3.27%).HELCCproducedasignificantreductionintheareas
damagedbyindomethacin,atalldosestested:0.63±0.11%a t
250mg/kg (reduction of 95.00%), 0.33 ± 0.08%a t5 0 0m g / k g
(97.38%), and 0.47 ± 0.17% at 750mg/kg (97.38%), respec-
t i v e l y ,w h e nc o m p a r e dt ot h ec o n t r o l( 𝑃 < 0.001 in all cases).
The animals that received omeprazole (30mg/kgp.o.) also
showed significant reduction in gastric lesion area and a sub-
stantial percentage reduction in ulcer area, that is, 0.40 ±
0.24% and 96.82%, respectively, compared to control (𝑃 <
0.001).
In the evaluation of the role of nitric oxide (NO) in the
protectiveeffectofHELCCagainstgastriclesionsinducedby
absoluteethanolinmice,itwasobservedthattheanimalsthat
received only vehicle combined with oral administration of
absolute ethanol showed gastric lesion (20.52 ± 2.29%).Th e
animals that received L-NAME (10mg/kg, i.p.), an inhibitor
of nitric oxide synthase (NOS), along with absolute ethanol
(0.2mL/animal, p.o.), also showed a large percentage of
ulcerated area (28.73 ± 3.83%).H o w e v e r ,t h ea n i m a l st h a t
received L-arginine (600mg/kg, p.o.) in combination with
absolute ethanol exhibited reductions in injured area (1.47 ±Evidence-Based Complementary and Alternative Medicine 5
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Figure 3: Effect of oral administration of the HEFCC in gastric
lesionsinducedbyindomethacininmice.Significance
∗∗∗𝑃 < 0.001
when compared with control group.
0.38%),withpercentageofulcerreductionof92.83%.HELCC
(75mg/kg,p.o.)producedasignificant(𝑃 < 0.001)reduction
in ulcerated area to 1.11±0.67% or a percentage reduction of
94.59%, compared to control. However, HELCC (75mg/kg,
p.o.),whengivenwithL-NAME(10mg/kg,i.p.),haditseffect
blocked, resulting in a percentage of ulcerated area of 30.65±
6.55%( Figure 4).
I nt h ei n v e s t i g a t i o no ft h er o l eo fp r o s t a g l a n d i n si nt h e
protectiveeffectofHELCCagainstgastriclesionsinducedby
absolute ethanol in mice, it was seen that the animals that
received only vehicle in combination with oral administra-
tionofabsoluteethanolshowedagastriclesionareaof18.57±
1.87%. The animals that received indomethacin (10mg/kg,
s.c.) together with absolute ethanol (0.2mL/animal, p.o.)
displayed a percentage of ulcerated area of 13.09 ± 1.92%.
However,theanimalsthatreceivedmisoprostol(0.016mg/kg,
p.o.) combined with absolute ethanol showed reductions in
injured area (0.57 ± 0.25%), resulting in a percentage reduc-
tion of 96.95%. HELCC (75mg/kg, p.o.) produced a signi-
ficant (𝑃 < 0.001) reduction in ulcerated area to 1.11±0.67%
orapercentagereductionof94.02%,comparedtothecontrol.
H E L C C( 7 5m g / k g,p . o . )w h e nc o m b i n e dw i t hi n d o m e t h a c i n
(10mg/kg, s.c.) resulted in a percentage of ulcerated area of
3.95 ± 1.15% and a percentage reduction in ulcer area of
78.72% (Figure 5).
In the investigation of the role of the alpha-2 noradrener-
gic receptor in the protective effect of HELCC against gastric
lesions induced by absolute ethanol in mice, it was seen that
the animals that received only vehicle combined with oral
administration of absolute ethanol showed a gastric lesion
area of 23.22 ± 2.08%. The animals that received yohimbine
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Figure 4: The role of nitric oxide (NO) in the gastroprotector effect
of the HEFCC in gastric lesions model induced by ethanol absolute
in mice. Significance
a𝑃 < 0.001 versus CL,
b𝑃 < 0.001 versus L-
NAME(10mg/Kg,v.o.),and
c𝑃 < 0.001versusL-NAME(10mg/kg,
v.o.) + EHFCC (75 mg/kg, v.o.).
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Figure 5: The role of prostaglandins in gastroprotector effect of the
HEFCCingastriclesionmodelinducedbyethanolabsoluteinmice.
Significance
a𝑃 < 0.001versusCL,
b𝑃 < 0.01versusCL,
c𝑃 < 0.001
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(2mg/kg,i.p.)togetherwithabsoluteethanol(0.2mL/animal,
p.o.) exhibited an extensive ulcerated area of 30.34 ± 4.96%.
HELCC (75mg/kg, p.o.) produced a significant (𝑃 < 0.001)
reduction in ulcerated area to 0.91 ± 0.63%o rap e r c e n t a g e
reduction of 96.34%, compared to the control. Also, HELCC
(75mg/kg,p.o.)giventogetherwithyohimbine(2mg/kg,i.p.)
produced a significant (𝑃 < 0.01) gastroprotectiveeffect with
a percentage of ulcerated area of 9.30±0.59%o rape r c e n ta g e
reduction in ulcer area of 59.94% (Figure 6).
In the evaluation of the involvement of ATP-dependent
K
+ channelsin theprotectiveeffect of HELCCagainst gastric
lesions induced by absolute ethanol in mice, it was observed
that the animals that received only vehicle in combination
with oral administration of absolute ethanol displayed a gas-
tric lesion area of (17.17 ± 2.44%). The animals that received
glibenclamidee (5mg/kg, i.p.) along with absolute ethanol
(0.2mL/animal, p.o.) showed an ulcerated area of 13.30 ±
2.25%). HELCC (75mg/kg, p.o.) produced a significant (𝑃 <
0.001) reduction in ulcerated area to 1.11 ± 0.67%o rp e r -
centage reduction of 91.65%, compared to the control. Also,
HELCC (75mg/kg, p.o.) when given with glibenclamidee
(5mg/kg,i.p.)stillexertedasignificantgastroprotectiveeffect
(𝑃 < 0.001)withapercentageofulceratedareaof1.23±0.53%
or percentage reduction in ulcer area of 90.75% (Figure 7).
3.3. Evaluation of Intestinal Motility. The percentage of the
distance traveled by the marker (activated charcoal) in the
small intestine of mice was (82.77±4.29%).Th ea n i m a l st h a t
received HELCC (75mg/kg) orally had a distance traveled
by the marker (84.20 ± 3.94%) that was similar to that
obtained by vehicle group, demonstrating that HELCC did
not significantly affect gastrointestinal motility. However, in
thegrouptreatedwithatropine(0.01g/kg,p.o.),amuscarinic
antagonist, there was a decrease in intestinal motility with a
distance traveled of 63.21 ± 2.05%, compared to the vehicle
control group (saline, p.o.), showing a significant effect (𝑃 <
0.01), as seen in the data presented in Figure 8.
4. Discussion
Several species of the genus Croton have played an important
role in traditional uses of medicinal plants in Africa, Asia,
and South America. Such uses include the treatment of
cancer, constipation, diarrhea and other digestive problems,
external wounds, diabetes, dyslipidemia, hypertension, fever,
inflammation, intestinal worms, malaria, pain, ulcers, and
obesity [9]. In the toxicological evaluation, HELCC did not
show signs of significant acute toxicity in the animals tested
and at all doses administered, corroborating a previous study
that demonstrated the low acute toxicity of Croton campestris
A. St.-Hill. in two guinea pigs [28].
As seen in the evaluation of the gastroprotective activity
of HELCC, experimental animals play an important role in
the search for new drugs with protective properties. Consid-
ering that the etiology of ulcer is multifactorial, lesions in
the gastric mucosa can be induced in different experimental
models through various mechanisms [29]. Some of the most
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Figure 6: The role of noradrenergic receptor alpha2 in the gas-
troprotector effect of HEFCC in gastric lesion model induced by
ethanol abs in mice. Significance
a𝑃 < 0.001 versus CL,
b𝑃 < 0.001
versus glibenclamide (5mg/kg, i.p.).
u s e da c u t em o d e l sf o rt h ee v a l u a t i o no fa n t i u l c e r o g e n i cs u b -
sta ncesina nimalsa r ethemodelso fgastriclesio nind ucedb y
absolute ethanol or indomethacin [30]. In this work, besides
the use of these methodologies, the effects of HELCC were
also evaluated with the gastric ulceration model using acidi-
fied ethanol.
Ethanol-induced gastric ulcer occurs predominantly in
the glandular portion of the stomach, as a result of a direct
necrotizing action and, moreover, the lack of defense factors
such as secretion of bicarbonate and mucus and increased
oxidativestress[31].HELCCatalldosestestedbyoraladmin-
istration prevented, in a dose-dependent manner, gastric
lesion induced by the administrationof absolute ethanol. The
doses decreased the percentage of gastric ulcer area in the
same manner as with omeprazole, a well-known proton
pump inhibitor, when compared to the vehicle-treated con-
trol lesion group. It was also demonstrated that the gastro-
protective action of HELCC at all orally administered doses,
against gastric ulcer induced by acidified ethanol, resulted
in a percentage reduction in ulcer area similar to that with
omeprazole, in comparison with the vehicle-treated control
lesion group.
Indomethacin like the majority of nonsteroidal anti-
inflammatory drugs (NSAIDs) acts as an inhibitor of pros-
taglandin synthesis and consequently diminishes the defense
mechanisms of gastric mucus [32–34]. It is the primary
mechanism by which this class of drugs cause, damage to the
gastrointestinal tract [35].
This research demonstrates the ability of the HELCC to
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Figure7:TheroleofATP-dependentK+channelsinthegastropro-
tector effect of HEFCC in gastric lesion model induced by ethanol
absolute in mice. Significance
a𝑃 and
a𝑃 < 0.001 versus CL,
b𝑃 <
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used a classic model of induction of gastric lesion by s.c.
indomethacin. Orally administered HELCC, at the doses
tested,wasabletopreventtheappearanceofgastriclesionsin
animalssubjectedtothetreatmentwiththisNSAID,showing
significant results when compared to the gastric lesion con-
trol.
Among the various factors involved in maintaining the
integrity of the gastric mucus and protection against injury
caused by ulcerogenic agents, we examined the contribution
of endogenous nitric oxide, prostaglandins, ATP-sensitive
potassium channels (KATP), and alpha-2 noradrenergic
receptor [36, 37] to the action of HELCC on the gastric
mucosa.
The discovery of nitric oxide (NO) as an agent of cell
signaling was one of the most important events in human
physiology of the last 80–90 years. NO is a free radical gas,
which has drawn attention because of its role in signal trans-
duction related to various physiological processes such as
smooth muscle relaxation and vasodilation, neurotransmis-
sion,plateletaggregationmechanisms,regulationofpro-and
antiapoptoticmechanisms,andcontrolofbloodpressureand
blood flow [38, 39].
Related to the modulation of the physiological compo-
nents of gastrointestinal tract, NO plays an important role in
thecontrolofgastrointestinalmotility[40],gastricbloodflow
[41], recruitment of neutrophils [42], and secretion of mucus
[43].
In the present research, the assessment of the role of NO
in the gastroprotective effect of HELCC in models of gastric
lesions, induced by ethanol in mice, showed that the ani-
mals that received L-NAME (a nonspecific inhibitor of NO
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Figure 8: The effect of HEFCC on intestinal motility in mice.
Significance
∗∗𝑃 < 0.01 versus C (vehicle control).
synthase), showed a large ulcerated gastric area, after admin-
istration of absolute ethanol, as in the control lesion group.
HELCC managed to inhibit the appearance of gastric lesions
in the gastroprotection model using L-NAME. The extract in
this situation showed a non-significant percentage reduction
in ulcer area. Similarly, it was seen that the L-arginine (a sub-
strate of NO synthase) significantly reduced the percentage
of ulcerated gastric area when compared with the vehicle-
treated control lesion group. This suggests that the com-
pounds present in the extract that exert a gastroprotective
effect involving the cytoprotective effect of NO.
Consideringthetraditionaluseoftheleavesofthespecies
Croton campestris A. St.-Hill. for gastric disturbances, in the
f o rmo ft ea sa n dinfu sio n,a n dinviewo fth ep r esen ceo fs uc h
secondarymetabolitesastannins,flavonoids,andalkaloidsin
theextract,itispossibletocorrelatetheantiulcerogeniceffect
demonstrated by the plant with these compounds. Also, it is
possible to correlate studies that demonstrate an association
between plant species that contain tannins, flavonoids, and
alkaloids and gastroprotective effects [44, 45], as probably
occur with Croton campestris A. St.-Hill.
The protective action of prostaglandins (PGs) on the
gastric mucosa is mediated by an increase in mucus produc-
tion and secretion of bicarbonate, modulation of gastric acid
secretion,inhibitionofthereleaseofinflammatorymediators
bymastcells,andthemaintenanceofbloodflowduringexpo-
sure to irritants. It is known that prostaglandin E2 (PGE2)
hasagastroprotectiveactionagainstlesionscausedbyethanol
and that this protection stems from an increase in intracellu-
lar guanosine-3
򸀠,5
򸀠-cyclic monophosphate(cGMP), which is
mediated by an increase in intracellular free calcium concen-
tration and nitric oxide production [46].8 Evidence-Based Complementary and Alternative Medicine
Intheevaluationofapossibleinvolvementofprostaglan-
dins in the gastroprotective effect of HELCC, we used miso-
prostol, an analogue of prostaglandin E1 (PGE1), as well as
indomethacin, and an inhibitor of PG synthesis. Misoprostol
significantly inhibited the development of gastric lesions
whencomparedwiththevehicle-treatedcontrollesiongroup.
Pretreatmentwithindomethacindidnotreversethecytopro-
tective effect of HELCC, demonstrating just a trend in this
direction. On the basis of this result, we cannot state that
prostaglandins play a role in the relaxant effect of HELCC.
The modulation of 𝗼2 receptors located in the intramural
peripheral parasympathetic ganglia decreases the discharge
of vagal acetylcholine, which reduces gastric secretion and
motility and increases blood flow. The 𝗼2-noradrenergic
receptors and the 𝗼2p r e s y n a p t i ca r ei n v o l v e di nt h er e g u l a -
tion of gastric acid secretion and are effective in protection
against chemical agents such as NSAIDs and ethanol, where
theireffectsmaybemediatedcentralandperipheralreceptors
[47].
In our study, the administration of yohimbine (10mg/kg,
i.p.), an indole alkaloid that promotes the release of neuro-
transmitters by blocking the presynaptic 𝗼2 receptors [48],
did not reverse the HELCC effect. This indicates that the
gastroprotectiveeffectofHELCCdoesnotactbymodulation
of 𝗼2r e c e p t o ra c t i v i t y .
KATPchannelsareregulatedbyligandsandtheirmecha-
nismisdefinedbasedontheirsensitivitytointracellularATP,
which inhibits its activity. It has been postulated that KATP
channelsareinvolvedinavarietyofpathophysiologicalfunc-
tions in the stomach such as regulation of blood flow, gastric
acid secretion, and gastric muscle contractility [49]. In the
vascular system, these channels are related to the relaxation
ofvascularsmoothmuscle,havinganimportantroleinblood
pressure control. This vasodilation can be blocked by gly-
buride, a sulfonylurea that blocks KATP channels [50]. Our
studies showed that HELCC, when combined with gliben-
clamidee, significantly retained its gastroprotective effect,
indicatingthat the mechanism of actionof the active ingredi-
ents of the extract may not involve the stimulation of KATP
channels.
Another way in which HELCC could promoteprotection
o ft h eg a s t r i cm u c o s aw o u l db et h r o u g hi n c r e a s e dg a s t r o -
intestinal motility, so increased intestinal transit would acce-
lerate gastric emptying, thereby decreasing the effect of
aggressor acid in the stomach and duodenum. Cholinergic
innervation of the circular muscle layer of TGI, acting on
muscarinic receptors M1 and M3, is primarilyresponsible for
gastrointestinal motility.
In thissense, HELCCdid notsignificantlyalter the intes-
tinal transit of mice when compared to the vehicle group
(10%activatedcharcoal)andthegroupthatreceivedatropine,
which is a drug blocking the muscarinic action of acetyl-
choline.
5. Conclusion
In short, we demonstrate here for the first time that HELCC,
an extract of leaves of Croton campestris A. St.-Hill., has
a protective effect against acute gastric lesion induced by
absolute ethanol, acidified ethanol, or indomethacin in mice,
thus indicating a cytoprotective action of HELCC, which
occurs through the potentiation of the NO/cGMP pathway.
The leaves of C. campestris contain compounds (metabolites)
thatpossiblyactinsynergyintheactivationofdefensefactors
and in reducing aggressor factors of gastric mucosa, which
makes this extract promising for the development of new
therapies to combat gastropathy associated with NSAID-
induced peptic ulcer disease.
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